1. Home
  2. BHM vs CPIX Comparison

BHM vs CPIX Comparison

Compare BHM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHM
  • CPIX
  • Stock Information
  • Founded
  • BHM 2022
  • CPIX 1999
  • Country
  • BHM United States
  • CPIX United States
  • Employees
  • BHM N/A
  • CPIX N/A
  • Industry
  • BHM Real Estate Investment Trusts
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHM Real Estate
  • CPIX Health Care
  • Exchange
  • BHM Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • BHM 51.9M
  • CPIX 51.5M
  • IPO Year
  • BHM N/A
  • CPIX 2009
  • Fundamental
  • Price
  • BHM $9.99
  • CPIX $2.99
  • Analyst Decision
  • BHM Strong Buy
  • CPIX
  • Analyst Count
  • BHM 1
  • CPIX 0
  • Target Price
  • BHM $15.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • BHM 3.9K
  • CPIX 34.5K
  • Earning Date
  • BHM 01-01-0001
  • CPIX 11-04-2025
  • Dividend Yield
  • BHM 5.08%
  • CPIX N/A
  • EPS Growth
  • BHM N/A
  • CPIX N/A
  • EPS
  • BHM N/A
  • CPIX N/A
  • Revenue
  • BHM $71,496,000.00
  • CPIX $42,071,813.00
  • Revenue This Year
  • BHM N/A
  • CPIX N/A
  • Revenue Next Year
  • BHM N/A
  • CPIX N/A
  • P/E Ratio
  • BHM N/A
  • CPIX N/A
  • Revenue Growth
  • BHM 27.87
  • CPIX 11.34
  • 52 Week Low
  • BHM $9.30
  • CPIX $1.04
  • 52 Week High
  • BHM $14.81
  • CPIX $7.25
  • Technical
  • Relative Strength Index (RSI)
  • BHM 29.55
  • CPIX 37.33
  • Support Level
  • BHM $11.00
  • CPIX $3.41
  • Resistance Level
  • BHM $10.00
  • CPIX $3.54
  • Average True Range (ATR)
  • BHM 0.24
  • CPIX 0.19
  • MACD
  • BHM -0.01
  • CPIX -0.05
  • Stochastic Oscillator
  • BHM 20.74
  • CPIX 4.18

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: